Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6736847rdf:typepubmed:Citationlld:pubmed
pubmed-article:6736847lifeskim:mentionsumls-concept:C0027882lld:lifeskim
pubmed-article:6736847lifeskim:mentionsumls-concept:C0175243lld:lifeskim
pubmed-article:6736847lifeskim:mentionsumls-concept:C0039601lld:lifeskim
pubmed-article:6736847lifeskim:mentionsumls-concept:C0020514lld:lifeskim
pubmed-article:6736847lifeskim:mentionsumls-concept:C0312418lld:lifeskim
pubmed-article:6736847lifeskim:mentionsumls-concept:C0036667lld:lifeskim
pubmed-article:6736847pubmed:issue1lld:pubmed
pubmed-article:6736847pubmed:dateCreated1984-8-13lld:pubmed
pubmed-article:6736847pubmed:abstractTextHyperprolactinaemia was induced in castrated, testosterone-treated male rats using ectopic pituitary grafts under the kidney capsules. After 6 weeks the absolute refractory period of stria terminalis neurones in these animals did not differ significantly from long-term castrated rats (mean = 1.72 vs 1.69 ms) in spite of the presence of normal testosterone concentrations. Gonadally intact animals, and sham-operated castrated animals treated with testosterone, showed by comparison the characteristic significantly shorter absolute refractory period normally associated with testosterone stimulation (mean = 1.15 and 1.08 ms respectively). These results provide the first demonstration that hyperprolactinaemia can abolish central sensitivity to testosterone.lld:pubmed
pubmed-article:6736847pubmed:languageenglld:pubmed
pubmed-article:6736847pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6736847pubmed:citationSubsetIMlld:pubmed
pubmed-article:6736847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6736847pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6736847pubmed:statusMEDLINElld:pubmed
pubmed-article:6736847pubmed:monthJullld:pubmed
pubmed-article:6736847pubmed:issn0022-0795lld:pubmed
pubmed-article:6736847pubmed:authorpubmed-author:DixsonA FAFlld:pubmed
pubmed-article:6736847pubmed:authorpubmed-author:KendrickK MKMlld:pubmed
pubmed-article:6736847pubmed:issnTypePrintlld:pubmed
pubmed-article:6736847pubmed:volume102lld:pubmed
pubmed-article:6736847pubmed:ownerNLMlld:pubmed
pubmed-article:6736847pubmed:authorsCompleteYlld:pubmed
pubmed-article:6736847pubmed:pagination109-13lld:pubmed
pubmed-article:6736847pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6736847pubmed:meshHeadingpubmed-meshheading:6736847-...lld:pubmed
pubmed-article:6736847pubmed:meshHeadingpubmed-meshheading:6736847-...lld:pubmed
pubmed-article:6736847pubmed:meshHeadingpubmed-meshheading:6736847-...lld:pubmed
pubmed-article:6736847pubmed:meshHeadingpubmed-meshheading:6736847-...lld:pubmed
pubmed-article:6736847pubmed:meshHeadingpubmed-meshheading:6736847-...lld:pubmed
pubmed-article:6736847pubmed:meshHeadingpubmed-meshheading:6736847-...lld:pubmed
pubmed-article:6736847pubmed:meshHeadingpubmed-meshheading:6736847-...lld:pubmed
pubmed-article:6736847pubmed:meshHeadingpubmed-meshheading:6736847-...lld:pubmed
pubmed-article:6736847pubmed:meshHeadingpubmed-meshheading:6736847-...lld:pubmed
pubmed-article:6736847pubmed:meshHeadingpubmed-meshheading:6736847-...lld:pubmed
pubmed-article:6736847pubmed:meshHeadingpubmed-meshheading:6736847-...lld:pubmed
pubmed-article:6736847pubmed:meshHeadingpubmed-meshheading:6736847-...lld:pubmed
pubmed-article:6736847pubmed:meshHeadingpubmed-meshheading:6736847-...lld:pubmed
pubmed-article:6736847pubmed:meshHeadingpubmed-meshheading:6736847-...lld:pubmed
pubmed-article:6736847pubmed:year1984lld:pubmed
pubmed-article:6736847pubmed:articleTitleHyperprolactinaemia abolishes sensitivity of stria terminalis neurones to testosterone.lld:pubmed
pubmed-article:6736847pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6736847pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed